"Crosstalk between ROR1 and the Pre-B Cell Receptor Promotes Survival of t(1;19) Acute Lymphoblastic Leukemia," Cancer Cell (Vol: 22, Issue: 5, Page 656-667) - 2012
"An adaptive Src-PDGFRA-Raf axis in rhabdomyosarcoma," Biochemical and Biophysical Research Communications (Vol: 426, Issue: 3, Page 363-368) - 2012
"Effects of plerixafor in combination with BCR-ABL kinase inhibition in a murine model of CML," Blood (Vol: 120, Issue: 13, Page 2658-2668) - 2012
"Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia," Leukemia (Vol: 26, Issue: 9, Page 2144-2146) - 2012
"In vitro sensitivity to dasatinib in lymphoblasts from a patient with t(17;19)(q22;p13) gene rearrangement pre-B acute lymphoblastic leukemia," Pediatric Blood and Cancer (Vol: 59, Issue: 3, Page 576-579) - 2012
"Creation of fibrinogen-enhanced experimental blood clots to evaluate mechanical thrombectomy devices for treatment of acute stroke: An in vitro study," Journal of Vascular and Interventional Radiology (Vol: 23, Issue: 8, Page 1077-1083) - 2012
"TSLP signaling network revealed by SILAC-based phosphoproteomics.," Molecular & cellular proteomics : MCP (Vol: 11, Issue: 6, Page M112.017764) - 2012
"TSLP signaling network revealed by SILAC-based phosphoproteomics," Molecular and Cellular Proteomics (Vol: 11, Issue: 6, Page ) - 2012
"TNFα facilitates clonal expansion of JAK2 V617F positive cells in myeloproliferative neoplasms," Blood (Vol: 118, Issue: 24, Page 6392-6398) - 2011
"Potent activity of ponatinib (AP24534) in models of FLT3-driven acute myeloid leukemia and other hematologic malignancies," Molecular Cancer Therapeutics (Vol: 10, Issue: 6, Page 1028-1035) - 2011
"Association of JAK2 mutation status and cytogenetic abnormalities in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms," American Journal of Clinical Pathology (Vol: 135, Issue: 5, Page 709-719) - 2011
"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity (Journal of Clinical Investigation (2011) 121, 1, (396-409) DOI: 10.1172/JCI35721)," Journal of Clinical Investigation (Vol: 121, Issue: 3, Page 1222-) - 2011
"CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability," Blood (Vol: 117, Issue: 2, Page 591-594) - 2011
"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity," Journal of Clinical Investigation (Vol: 121, Issue: 1, Page 396-409) - 2011
"Survey of activated FLT3 signaling in leukemia," PLoS ONE (Vol: 6, Issue: 4, Page ) - 2011
"MET receptor sequence variants R970C and T992I lack transforming capacity," Cancer Research (Vol: 70, Issue: 15, Page 6233-6237) - 2010
"CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms," Blood (Vol: 115, Issue: 25, Page 5232-5240) - 2010
"Small intestinal submucosa plug for closure of dilated nephrostomy tracts: A pilot study in swine," CardioVascular and Interventional Radiology (Vol: 33, Issue: 3, Page 596-600) - 2010
"Thrombus formation after percutaneous catheterization and manual compression of the femoral artery in heparinized sheep," CardioVascular and Interventional Radiology (Vol: 33, Issue: 2, Page 321-329) - 2010
"A gene expression signature of CD34+ cells to predict major cytogenetic response in chronic-phase chronic myeloid leukemia patients treated with imatinib," Blood (Vol: 115, Issue: 2, Page 315-325) - 2010
